President Donald Trump on Thursday nominated Dr. Nicole B. Saphier, a breast-imaging specialist at Memorial Sloan Kettering Cancer Center, to serve as surgeon general, moving swiftly to replace Dr. Casey Means after her nomination stalled in the Senate. The switch came less than half an hour after Trump announced on Truth Social that Means would be withdrawn, marking his third attempt to fill the post in his second term.
The rapid pivot underscores a White House determined to keep its Make America Healthy Again agenda on track, even as Senate resistance forced a high-profile retreat. It also lands a fresh blow to Health and Human Services Secretary Robert F. Kennedy Jr., whose preferred candidate could not survive the confirmation gauntlet.
The Daily Caller reported that Trump praised Saphier as a "star physician" who has spent her career guiding women through breast cancer diagnosis and treatment. In his Truth Social post, the president highlighted her work on early cancer detection and prevention.
"She is also an incredible communicator who makes complicated health issues more easily understood by all Americans."
The White House did not respond to a request for comment on the nomination.
Means was nominated last May as a replacement for Dr. Janette Nesheiwat, Trump's original surgeon general pick. From the start, her path was rocky. Her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions was postponed in late 2025, and when it finally took place earlier this year, she failed to gather enough votes to advance.
Senators raised pointed questions about her medical experience, her views on vaccines, and the fact that she does not hold an active medical license, a combination that eroded support on both sides of the aisle. The Washington Times reported that those concerns had effectively doomed her candidacy well before Thursday's announcement.
As we previously reported, Trump had signaled for weeks that he might pull the Means nomination amid growing GOP resistance. Thursday's move made it official.
Trump laid blame squarely on Sen. Bill Cassidy, the Louisiana Republican who chairs the HELP committee. In his Truth Social post withdrawing Means, the president accused Cassidy of "intransigence and political games" and called him a "very disloyal person" who had used Trump's endorsement to win election before voting to impeach him.
Still, Trump struck a conciliatory note toward Means herself, saying she would continue to champion the MAHA cause outside the surgeon general's office:
"Casey will continue to fight for MAHA on the many important health issues facing our country, such as the rising childhood disease epidemic, increased autism rates, poor nutrition, over-medicalization, and researching the root causes of infertility, and many other difficult medical problems."
Saphier serves as director of breast imaging at Memorial Sloan Kettering Cancer Center Monmouth and hosts a program called "Wellness Unmasked." She is also a Fox News medical contributor, a detail that gives her a public profile most radiologists lack and may smooth her confirmation path by making her a familiar face to Republican senators.
Breitbart noted that Saphier is broadly aligned with the MAHA movement, though she has at times publicly differed with Trump on health messaging. That independent streak may actually serve as an asset in confirmation hearings, signaling to skeptical senators that the nominee exercises her own medical judgment.
Her record on vaccine policy offers a window into her approach. In 2022, Saphier warned that the CDC would mandate coronavirus vaccines for schoolchildren. Then in 2025, she publicly asked the CDC and the American Academy of Pediatrics to allow parents to delay the MMR vaccine for their children.
In her own words, she urged the agencies to let parents "have that conversation and let them wait until their child's a little bit older." That position places her firmly within the parental-choice lane of the MAHA movement without veering into outright vaccine opposition, a distinction that may matter when she sits before the HELP committee.
The contentious confirmation fight over the surgeon general post has already produced sharp exchanges on Capitol Hill. Whether Saphier's medical credentials and communication skills can defuse that tension remains to be seen.
Saphier is now Trump's third nominee for surgeon general in this term alone, following Nesheiwat and Means. The revolving door reflects a broader challenge: the administration's health agenda is ambitious, but the Senate confirmation process keeps extracting a toll.
Newsmax described Means's withdrawal as a setback for Kennedy and the MAHA movement that had strongly supported her. Kennedy had preferred Means for the role and had planned to work alongside her to tackle chronic diseases.
The surgeon general shuffle is not the only personnel question facing the administration. Trump has also weighed changes at the intelligence directorate, suggesting a willingness to move quickly when nominees or appointees hit resistance.
The post of surgeon general carries symbolic weight beyond its formal authority. The officeholder serves as "America's doctor," shaping public-health messaging on everything from childhood nutrition to disease prevention. Under the Biden administration, the office drew scrutiny for its role in coordinating efforts to suppress COVID-era dissent, a controversy that makes the next occupant's approach to free inquiry and medical transparency all the more consequential.
Trump described Saphier as having "impeccable 'MAHA' credentials" in a post shared by the White House rapid-response account on X. The framing is deliberate: the administration wants to signal continuity on its health-reform agenda even as it swaps out the messenger.
Saphier's professional résumé is harder to attack than Means's was. She holds an active medical practice, directs a specialized imaging division at one of the nation's premier cancer centers, and has years of public-facing commentary that senators can review. None of that guarantees smooth sailing, Cassidy still chairs the committee, and the politics of vaccine policy remain combustible, but it narrows the lines of attack considerably.
The open questions are straightforward. Can Saphier secure the votes Means could not? Will Cassidy and the HELP committee schedule a hearing promptly, or will the same procedural delays that sank Means resurface? And will Kennedy's wing of the health-policy world embrace a nominee who was not their first, or second, choice?
The administration has burned through two surgeon general nominees in under a year. At some point, the Senate has to confirm one, or explain to voters why America's top public-health post sits empty while chronic disease rates keep climbing.
